Fund moves

Lifecore Biomedical, Inc. (LFCR): Alpha Wave Global, LP opened a new position $866K

Alpha Wave Global, LP opened a new position in Lifecore Biomedical, Inc., per its Q4 2024 13F.

117K
Shares reported
0.40%
Disclosed portfolio weight
$866K
Reported value
Holdings as of
Dec 31, 2024
Filed
Feb 13, 2025

What stands out in this filing

  • A new position in Q4 2024: 116,538 shares, none in the manager's Q3 2024 filing.
  • Reported at $866K, 0.40% of the portfolio value in this 13F filing.
  • No other tracked manager reported the same kind of change for Q4 2024.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 8, 2025InsiderCEO purchased ~$98K of LFCR shares in the open market

What came next

  1. May 5, 2025Insider10% owner sold ~$174K of LFCR shares in the open market
  2. May 6, 2025Insider10% owner sold ~$4.9K of LFCR shares in the open market
  3. May 7, 2025Insider10% owner sold ~$111K of LFCR shares in the open market
  4. May 8, 2025Insider10% owner sold ~$36K of LFCR shares in the open market
  5. May 9, 2025Insider10% owner sold ~$4.9K of LFCR shares in the open market
  6. May 12, 2025Insider10% owner sold ~$321K of LFCR shares in the open market
  7. May 13, 2025Insider10% owner sold ~$86K of LFCR shares in the open market
  8. May 23, 2025Insider10% owner sold ~$649K of LFCR shares in the open market
  9. May 27, 2025Insider10% owner sold ~$7.41M of LFCR shares in the open market
  10. May 28, 2025Insider10% owner sold ~$1.07M of LFCR shares in the open market
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Lifecore Biomedical, Inc.

OQRO holds no insider, Congress, fund or contract record for Lifecore Biomedical, Inc. dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LFCR page.

How this filing works

Explore the data

Common questions

What does this filing report about Lifecore Biomedical, Inc. (LFCR) stock?

Alpha Wave Global, LP opened a new position in Lifecore Biomedical, Inc., per its Q4 2024 13F. 117K shares reported, 0.40% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Dec 31, 2024. Filed: Feb 13, 2025.

What stands out in this filing?

A new position in Q4 2024: 116,538 shares, none in the manager's Q3 2024 filing. Reported at $866K, 0.40% of the portfolio value in this 13F filing. No other tracked manager reported the same kind of change for Q4 2024.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

Does this mean LFCR stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Lifecore Biomedical, Inc.

Everything OQRO holds on this company is on its LFCR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data